US2009275664A1PendingUtilityA1

Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases

64
Assignee: FRYDMAN BENJAMINPriority: Apr 30, 1999Filed: Jul 15, 2009Published: Nov 5, 2009
Est. expiryApr 30, 2019(expired)· nominal 20-yr term from priority
A61P 35/00A61P 43/00C07C 211/18C07D 493/04A61P 15/00C07D 207/34C07D 311/92C07D 235/18C07D 295/185A61K 38/00C07K 7/06C07C 2601/02C07D 219/10C07D 307/79A61K 47/65C07C 67/343A61P 13/08C07D 317/70C07K 5/1013C07D 307/92C07C 211/13C07C 45/46
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Peptide conjugates in which cytocidal and cytostatic agents, such as polyamine analogs or naphthoquinones, are conjugated to a polypeptide recognized and cleaved by enzymes such as prostate-specific antigen (PSA) and cathepsin B are provided, as well as compositions comprising these conjugates. Methods of using these conjugates in the treatment of prostate diseases are also provided.

Claims

exact text as granted — not AI-modified
1 - 46 . (canceled) 
     
     
         47 . A compound selected from the group consisting of 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       and all pharmaceutically-suitable salts and stereoisomers thereof. 
     
     
         48 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         49 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         50 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         51 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         52 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         53 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         54 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         55 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         56 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         57 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         58 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         59 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         60 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         61 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         62 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         63 . A compound of  claim 47  of the formula: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically-suitable salt or a stereoisomer thereof. 
     
     
         64 . A method of treating cancer, comprising administering to an individual a therapeutic amount of one or more of the compounds of  claim 47 , or a pharmaceutically-suitable salt or stereoisomer thereof. 
     
     
         65 . The method of  claim 64 , wherein the cancer is prostate cancer. 
     
     
         66 . The method of  claim 64 , wherein the cancer is breast cancer. 
     
     
         67 . The method of  claim 64 , wherein the cancer is brain cancer. 
     
     
         68 . The method of  claim 64 , wherein the cancer is colon cancer. 
     
     
         69 . The method of  claim 64 , wherein the cancer is lung cancer.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.